Search by PDB author

Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitrobenzoyl)-3-O-(4-methylbenzoyl)-b-D-talopyranoside
Descriptor:	CHLORIDE ION, Galectin-3, methyl 3-O-(4-methylbenzoyl)-2-O-(2-nitrobenzoyl)-beta-D-talopyranoside
Authors:	Bum-Erdene, K, Kishor, C, Blanchard, H.
Deposit date:	2021-07-15
Release date:	2022-07-13
Last modified:	2023-10-18
Method:	X-RAY DIFFRACTION (1.58 Å)
Cite:	Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia. J.Med.Chem., 65, 2022

Galectin-3 carbohydrate recognition domain in complex with thioditaloside
Descriptor:	CHLORIDE ION, Galectin-3, beta-D-talopyranose-(1-1)-1-thio-beta-D-talopyranose
Authors:	Bum-Erdene, K, Blanchard, H.
Deposit date:	2013-02-22
Release date:	2013-07-31
Last modified:	2024-02-28
Method:	X-RAY DIFFRACTION (1.15 Å)
Cite:	Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitors. Chembiochem, 14, 2013

Crystal structure of BCII Metallo-beta-lactamase in complex with KDU197
Descriptor:	(~{Z})-3-[2-(naphthalen-2-ylmethyl)phenyl]-2-sulfanyl-prop-2-enoic acid, Metallo-beta-lactamase type 2, SULFATE ION, ...
Authors:	McDonough, M.A, El-Hussein, A, Schofield, C.J, Zhang, D, Brem, J.
Deposit date:	2017-11-24
Release date:	2018-10-03
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.149 Å)
Cite:	Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-beta-lactamases. Bioorg. Med. Chem., 26, 2018